|Bid||0.6550 x 2200|
|Ask||0.6571 x 900|
|Day's Range||0.6563 - 0.7399|
|52 Week Range||0.6400 - 3.4700|
|Beta (5Y Monthly)||4.65|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 21, 2022 - Feb 25, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TORONTO, December 01, 2021--Titan Medical Announces CEO Transition
TORONTO, November 11, 2021--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of its innovative surgical technologies for robotic-assisted surgery that requires a single patient access point, today announced financial results for the three and nine months ended September 30, 2021.
The medical device company established its U.S. headquarters in the Triangle last year and has been growing its local headcount ever since as it works toward commercialization.